Jianerkang Medical Co., Ltd. (SHA:603205)

Jianerkang Medical Statistics

Total Valuation

SHA:603205 has a market cap or net worth of CNY 4.60 billion. The enterprise value is 3.85 billion.

Market Cap	4.60B
Enterprise Value	3.85B

Important Dates

The last earnings date was Friday, June 20, 2025.

Earnings Date	Jun 20, 2025
Ex-Dividend Date	Jul 9, 2025

Share Statistics

SHA:603205 has 156.00 million shares outstanding. The number of shares has increased by 13.77% in one year.

Current Share Class	156.00M
Shares Outstanding	156.00M
Shares Change (YoY)	+13.77%
Shares Change (QoQ)	+10.46%
Owned by Insiders (%)	66.00%
Owned by Institutions (%)	0.92%
Float	41.34M

Valuation Ratios

The trailing PE ratio is 31.64.

PE Ratio	31.64
Forward PE	n/a
PS Ratio	4.28
PB Ratio	3.17
P/TBV Ratio	3.30
P/FCF Ratio	61.52
P/OCF Ratio	39.80
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.00, with an EV/FCF ratio of 51.52.

EV / Earnings	31.05
EV / Sales	3.58
EV / EBITDA	23.00
EV / EBIT	30.91
EV / FCF	51.52

Financial Position

The company has a current ratio of 10.28

Current Ratio	10.28
Quick Ratio	8.61
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	24,421.28

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	8.39%
Revenue Per Employee	656,148
Profits Per Employee	75,743
Employee Count	1,638
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, SHA:603205 has paid 18.16 million in taxes.

Income Tax	18.16M
Effective Tax Rate	12.77%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	29.85
200-Day Moving Average	n/a
Relative Strength Index (RSI)	47.07
Average Volume (20 Days)	1,723,683

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:603205 had revenue of CNY 1.07 billion and earned 124.07 million in profits. Earnings per share was 0.93.

Revenue	1.07B
Gross Profit	246.09M
Operating Income	124.62M
Pretax Income	142.23M
Net Income	124.07M
EBITDA	167.50M
EBIT	124.62M
Earnings Per Share (EPS)	0.93

Balance Sheet

The company has 747.87 million in cash and n/a in debt, giving a net cash position of 747.87 million or 4.79 per share.

Cash & Cash Equivalents	747.87M
Total Debt	n/a
Net Cash	747.87M
Net Cash Per Share	4.79
Equity (Book Value)	1.45B
Book Value Per Share	9.30
Working Capital	1.03B

Cash Flow

In the last 12 months, operating cash flow was 115.59 million and capital expenditures -40.81 million, giving a free cash flow of 74.78 million.

Operating Cash Flow	115.59M
Capital Expenditures	-40.81M
Free Cash Flow	74.78M
FCF Per Share	0.48

Margins

Gross margin is 22.90%, with operating and profit margins of 11.60% and 11.54%.

Gross Margin	22.90%
Operating Margin	11.60%
Pretax Margin	13.23%
Profit Margin	11.54%
EBITDA Margin	15.58%
EBIT Margin	11.60%
FCF Margin	6.96%

Dividends & Yields

This stock pays an annual dividend of 0.27, which amounts to a dividend yield of 0.92%.

Dividend Per Share	0.27
Dividend Yield	0.92%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.77%
Shareholder Yield	-12.85%
Earnings Yield	2.70%
FCF Yield	1.63%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 9, 2025. It was a forward split with a ratio of 1.3.

Last Split Date	Jul 9, 2025
Split Type	Forward
Split Ratio	1.3

Scores

SHA:603205 has an Altman Z-Score of 22.56 and a Piotroski F-Score of 3.

Altman Z-Score	22.56
Piotroski F-Score	3